Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033. Tran JQ, Rana J, Barkhof F, Melamed I, Gevorkyan H, Wattjes MP, de Jong R, Brosofsky K, Ray S, Xu L, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Aug; 1(2):e18. Epub 2014 Aug 21. PMID: 25340070. Abstract CommentRecommendBookmarkWatch